메뉴 건너뛰기




Volumn 9, Issue 8, 1998, Pages 551-567

Fluticasone propionate in the treatment of asthma in adults and adolescents

Author keywords

[No Author keywords available]

Indexed keywords

ANTIASTHMATIC AGENT; BECLOMETASONE DIPROPIONATE; BUDESONIDE; FLUNISOLIDE; FLUTICASONE PROPIONATE; NEDOCROMIL SODIUM; PREDNISOLONE; SALBUTAMOL; SALMETEROL; THEOPHYLLINE; TRIAMCINOLONE ACETONIDE; ZAFIRLUKAST;

EID: 0031761589     PISSN: 09548602     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review
Times cited : (5)

References (42)
  • 1
    • 0142060245 scopus 로고
    • Equipotency of budesonide and fluticasone propionate in the vasoconstriction assay
    • Andersson N, Klint S, Randwell G et al. Equipotency of budesonide and fluticasone propionate in the vasoconstriction assay. Am J Respir Crit Care Med 1994; 149 (Suppl 4): A467.
    • (1994) Am J Respir Crit Care Med , vol.149 , Issue.4 SUPPL.
    • Andersson, N.1    Klint, S.2    Randwell, G.3
  • 2
    • 0029075287 scopus 로고
    • High dose fluticasone propionate, 1 mg daily, versus fluticasone propionate, 2 mg daily, or budesonide, 1.6 mg daily, in patients with chronic severe asthma
    • Ayres JG, Bateman ED, Lundbäck B, Harris TAJ, on Behalf of an International Study Group. High dose fluticasone propionate, 1 mg daily, versus fluticasone propionate, 2 mg daily, or budesonide, 1.6 mg daily, in patients with chronic severe asthma. Eur Resp J 1995; 8: 579-586.
    • (1995) Eur Resp J , vol.8 , pp. 579-586
    • Ayres, J.G.1    Bateman, E.D.2    Lundbäck, B.3    Harris, T.A.J.4
  • 3
    • 0000920267 scopus 로고    scopus 로고
    • A comparison of fluticasone propionate via Diskus™ (Accuhaler™) inhaler and budesonide via Turbuhaler™ inhaler in adult asthmatics
    • Backman R, Pickering CAC, Baumgarten C, Huskisson SC. A comparison of fluticasone propionate via Diskus™ (Accuhaler™) inhaler and budesonide via Turbuhaler™ inhaler in adult asthmatics. J Allergy Clin Immunol 1996; 97: 249.
    • (1996) J Allergy Clin Immunol , vol.97 , pp. 249
    • Backman, R.1    Pickering, C.A.C.2    Baumgarten, C.3    Huskisson, S.C.4
  • 4
    • 0027288321 scopus 로고
    • A comparison of fluticasone propionate, 1 mg daily, with beclomethasone dipropionate, 2 mg daily, in the treatment of severe asthma
    • Barnes NC, Marone G, DiMaria GU et al. A comparison of fluticasone propionate, 1 mg daily, with beclomethasone dipropionate, 2 mg daily, in the treatment of severe asthma. Eur Respir J 1993; 6: 877-884.
    • (1993) Eur Respir J , vol.6 , pp. 877-884
    • Barnes, N.C.1    Marone, G.2    DiMaria, G.U.3
  • 5
    • 0031888153 scopus 로고    scopus 로고
    • Clinical experience with fluticasone propionate in asthma: A meta-analysis of efficacy and systemic activity compared with budesonide and beclomethasone dipropionate at half the microgram dose or less
    • Barnes NC, Hallett C, Harris TAJ. Clinical experience with fluticasone propionate in asthma: a meta-analysis of efficacy and systemic activity compared with budesonide and beclomethasone dipropionate at half the microgram dose or less. Respir Med 1998; 92: 95-104.
    • (1998) Respir Med , vol.92 , pp. 95-104
    • Barnes, N.C.1    Hallett, C.2    Harris, T.A.J.3
  • 6
    • 9344259603 scopus 로고
    • The effect of inhaled fluticasone propionate (FP), a new potent corticosteroid in severe asthma
    • Bauer K, Bantje TA, Sips AP et al. The effect of inhaled fluticasone propionate (FP), a new potent corticosteroid in severe asthma. Eur Respir J 1988; 1 (Suppl 2): 201s.
    • (1988) Eur Respir J , vol.1 , Issue.2 SUPPL.
    • Bauer, K.1    Bantje, T.A.2    Sips, A.P.3
  • 7
    • 0024543839 scopus 로고
    • A self-management plan in the treatment of adult asthma
    • Beasley R, Cushley M, Holgate ST. A self-management plan in the treatment of adult asthma. Thorax 1989; 44: 200-204.
    • (1989) Thorax , vol.44 , pp. 200-204
    • Beasley, R.1    Cushley, M.2    Holgate, S.T.3
  • 8
    • 13044262065 scopus 로고    scopus 로고
    • A six month comparison of the efficacy of high dose fluticasone propionate (FP) with beclomethasone dipropionate (BDP) and budesonide (BUD) in adults with severe asthma
    • Berend N. A six month comparison of the efficacy of high dose fluticasone propionate (FP) with beclomethasone dipropionate (BDP) and budesonide (BUD) in adults with severe asthma. Eur Respir J 1997; 10 (Suppl 25): 105s.
    • (1997) Eur Respir J , vol.10 , Issue.25 SUPPL.
    • Berend, N.1
  • 9
    • 0024893189 scopus 로고
    • Effectiveness of nedocromil sodium versus placebo as additions to routine asthma maintenance therapy: A multicentre, double-blind, group comparative trial
    • Bianco S, del Bono N, Grassi V et al. Effectiveness of nedocromil sodium versus placebo as additions to routine asthma maintenance therapy: a multicentre, double-blind, group comparative trial. Respiration 1989; 56: 204-211.
    • (1989) Respiration , vol.56 , pp. 204-211
    • Bianco, S.1    Del Bono, N.2    Grassi, V.3
  • 10
    • 0024322527 scopus 로고
    • Comparison of dose-response eflects of inhaled beclomethasone dipropionate and budesonide in the management of asthma
    • Boe J, Rosenhall L, Alton M et al. Comparison of dose-response eflects of inhaled beclomethasone dipropionate and budesonide in the management of asthma. Allergy 1989; 44: 349-355.
    • (1989) Allergy , vol.44 , pp. 349-355
    • Boe, J.1    Rosenhall, L.2    Alton, M.3
  • 11
    • 0028576801 scopus 로고
    • High dose inhaled steroids in asthmatics: Moderate efficacy gain and suppression of the hypothalamus-pituitary-adrenal (HPA) axis
    • Boe J, Bakke P, Rødølen T et al. High dose inhaled steroids in asthmatics: moderate efficacy gain and suppression of the hypothalamus-pituitary-adrenal (HPA) axis. Eur Respir J 1994; 7: 2179-2184.
    • (1994) Eur Respir J , vol.7 , pp. 2179-2184
    • Boe, J.1    Bakke, P.2    Rødølen, T.3
  • 12
    • 4244026898 scopus 로고
    • Effects of fluticasone propionate and beclomethasone dipropionate on parameters of inflammation in the peripheral blood of patients with asthma
    • Bootsma GP, Dekhuijzen PNR, Festen J, van Herwaarded CLA. Effects of fluticasone propionate and beclomethasone dipropionate on parameters of inflammation in the peripheral blood of patients with asthma. Am J Respir Crit Care Med 1995a; 151: A387.
    • (1995) Am J Respir Crit Care Med , vol.151
    • Bootsma, G.P.1    Dekhuijzen, P.N.R.2    Festen, J.3    Van Herwaarded, C.L.A.4
  • 13
    • 8244235867 scopus 로고
    • Comparison of fluticasone propionate and beclomethasone dipropionate on direct and indirect measurements of bronchial hyperresponsiveness
    • Bootsma GP, Dekhuijzen PNR, Festen J, van Herwaarded CLA. Comparison of fluticasone propionate and beclomethasone dipropionate on direct and indirect measurements of bronchial hyperresponsiveness. Am J Respir Crit Care Med 1995b; 151: A275.
    • (1995) Am J Respir Crit Care Med , vol.151
    • Bootsma, G.P.1    Dekhuijzen, P.N.R.2    Festen, J.3    Van Herwaarded, C.L.A.4
  • 14
    • 4243861538 scopus 로고    scopus 로고
    • Clinical equivalence of once vs twice daily administration of inhaled fluticasone propionate in the treatment of mild and moderate asthma
    • Boulet LP, Robson R, Stepner N, for the International Study Group. Clinical equivalence of once vs twice daily administration of inhaled fluticasone propionate in the treatment of mild and moderate asthma. Eur Resp J 1996; 9 (Suppl 23): 52s.
    • (1996) Eur Resp J , vol.9 , Issue.23 SUPPL.
    • Boulet, L.P.1    Robson, R.2    Stepner, N.3
  • 15
    • 4243811080 scopus 로고
    • Double-blind parallel group study to compare the long term clinical efficacy and safety of two different methods of administering inhaled fluticasone propionate in chronic severe asthmatic patients
    • Bousquet J, Tisserand B, Medley HV. Double-blind parallel group study to compare the long term clinical efficacy and safety of two different methods of administering inhaled fluticasone propionate in chronic severe asthmatic patients. Eur Resp J 1995; 8 (Suppl 19): 427s.
    • (1995) Eur Resp J , vol.8 , Issue.19 SUPPL.
    • Bousquet, J.1    Tisserand, B.2    Medley, H.V.3
  • 16
    • 0002537669 scopus 로고
    • Design, manufacture and dose consistency of the Serevent Diskus inhaler
    • Brindley A, Sumby BS, Smith IJ et al. Design, manufacture and dose consistency of the Serevent Diskus inhaler. Pharm Tech Eur 1995; 7: 14-22.
    • (1995) Pharm Tech Eur , vol.7 , pp. 14-22
    • Brindley, A.1    Sumby, B.S.2    Smith, I.J.3
  • 17
    • 0027406017 scopus 로고
    • Guidelines on the management of asthma
    • British Thoracic Society. Guidelines on the management of asthma. Thorax 1993; 48 (Suppl 1): S1-S24.
    • (1993) Thorax , vol.48 , Issue.1 SUPPL.
  • 18
    • 0031034624 scopus 로고    scopus 로고
    • The British guidelines on asthma management. 1995 Review and position statement
    • British Thoracic Society. The British guidelines on asthma management. 1995 Review and position statement. Thorax 1997; 52 (Suppl): S1-S21.
    • (1997) Thorax , vol.52 , Issue.SUPPL.
  • 19
    • 0028150916 scopus 로고
    • Fluticasone propionate aerosol for the treatment of adults with mild to moderate asthma
    • Chervinsky P, van As A, Bronsky EA et al. Fluticasone propionate aerosol for the treatment of adults with mild to moderate asthma. J Allergy Clin Immunol 1994a; 94: 676-683.
    • (1994) J Allergy Clin Immunol , vol.94 , pp. 676-683
    • Chervinsky, P.1    Van As, A.2    Bronsky, E.A.3
  • 20
    • 26844445795 scopus 로고
    • Gender does not affect ability of fluticasone propionate aerosol to reduce oral prednisolone dose in severe asthma
    • Chervinsky P, Cook CK, Kellerman DJ, Kral KM. Gender does not affect ability of fluticasone propionate aerosol to reduce oral prednisolone dose in severe asthma. Allergy Clin Immunol News 1994b; Suppl 1: 20.
    • (1994) Allergy Clin Immunol News , vol.1 , Issue.SUPPL. , pp. 20
    • Chervinsky, P.1    Cook, C.K.2    Kellerman, D.J.3    Kral, K.M.4
  • 21
    • 26844540988 scopus 로고    scopus 로고
    • Fluticasone propionate 500 mcg/day is superior to triamcinolone acetonide 800 mcg/day in controlling asthma
    • Chervinsky P, Ginchansky E, Ayars G et al. Fluticasone propionate 500 mcg/day is superior to triamcinolone acetonide 800 mcg/day in controlling asthma. Eur Respir J 1996; 9 (Suppl 23): 78s.
    • (1996) Eur Respir J , vol.9 , Issue.23 SUPPL.
    • Chervinsky, P.1    Ginchansky, E.2    Ayars, G.3
  • 22
    • 0016756721 scopus 로고
    • Importance of dosage in local steroid treatment for asthma
    • Clark TJH. Importance of dosage in local steroid treatment for asthma. Foli Allergol Immunol Clin 1975; 22: 232.
    • (1975) Foli Allergol Immunol Clin , vol.22 , pp. 232
    • Clark, T.J.H.1
  • 23
    • 4243386447 scopus 로고    scopus 로고
    • Fluticasone propionate administered via the Diskus 500 μg once daily or 250 μg twice daily is safe and effective in adult patients with asthma
    • Clifford DP, Adelglass R, ZuWallack R et al. Fluticasone propionate administered via the Diskus 500 μg once daily or 250 μg twice daily is safe and effective in adult patients with asthma. Am J Respir Crit Care Med 1997; 155: A349.
    • (1997) Am J Respir Crit Care Med , vol.155
    • Clifford, D.P.1    Adelglass, R.2    Zuwallack, R.3
  • 24
  • 25
    • 0026087034 scopus 로고
    • Paradoxical bronchospasm after use of inhalation aerosols: A review of the literature
    • Cocchetto DM, Sykes RS, Spector S. Paradoxical bronchospasm after use of inhalation aerosols: a review of the literature. J Asthma 1991; 28: 49-53.
    • (1991) J Asthma , vol.28 , pp. 49-53
    • Cocchetto, D.M.1    Sykes, R.S.2    Spector, S.3
  • 26
    • 0030882724 scopus 로고    scopus 로고
    • Fluticasone propionate powder administered through Diskhaler versus triamcinolone acetonide aerosol administered through metered-dose inhaler in patients with persistent asthma
    • Condemi JJ, Chervinsky P, Goldstein MF et al. Fluticasone propionate powder administered through Diskhaler versus triamcinolone acetonide aerosol administered through metered-dose inhaler in patients with persistent asthma. J Allergy Clin Immunol 1997; 100: 467-474.
    • (1997) J Allergy Clin Immunol , vol.100 , pp. 467-474
    • Condemi, J.J.1    Chervinsky, P.2    Goldstein, M.F.3
  • 27
    • 0000379674 scopus 로고
    • A comparison of fluticasone propionate 100 μg twice daily with budesonide 200 μg twice daily via their respective powder devices in the treatment of mild asthma
    • Connolly A, on Behalf of a UK Study Group. A comparison of fluticasone propionate 100 μg twice daily with budesonide 200 μg twice daily via their respective powder devices in the treatment of mild asthma. Eur J Clin Res 1995; 7: 15-29.
    • (1995) Eur J Clin Res , vol.7 , pp. 15-29
    • Connolly, A.1
  • 28
    • 0016292471 scopus 로고
    • Response of patients receiving high dose beclomethasone dipropionate
    • Costello JF, Clark TJH. Response of patients receiving high dose beclomethasone dipropionate. Thorax 1974; 29: 571-573.
    • (1974) Thorax , vol.29 , pp. 571-573
    • Costello, J.F.1    Clark, T.J.H.2
  • 29
    • 26844544580 scopus 로고    scopus 로고
    • Improvement in general quality of life for asthmatics receiving inhaled fluticasone propionate (FP) 500 μg/day versus triamcinolone acetonide (TAA) 800 μg/day or placebo (PL)
    • Cox FM, Goodwin B, Cohen R, Rogenes P, Misniewski M. Improvement in general quality of life for asthmatics receiving inhaled fluticasone propionate (FP) 500 μg/day versus triamcinolone acetonide (TAA) 800 μg/day or placebo (PL). Eur Resp J 1996a; 9 (Suppl 23): 80s.
    • (1996) Eur Resp J , vol.9 , Issue.23 SUPPL.
    • Cox, F.M.1    Goodwin, B.2    Cohen, R.3    Rogenes, P.4    Misniewski, M.5
  • 30
    • 2642604749 scopus 로고    scopus 로고
    • Superior impact of inhaled fluticasone propionate 500 μg/day vs. triamcinolone acetonide 800 μg/day or placebo on asthma-specific quality of life in asthmatics
    • Cox FM, Goodwin B, Pepsin P et al. Superior impact of inhaled fluticasone propionate 500 μg/day vs. triamcinolone acetonide 800 μg/day or placebo on asthma-specific quality of life in asthmatics. Am J Respir Crit Care Med 1996b; 153: A340.
    • (1996) Am J Respir Crit Care Med , vol.153
    • Cox, F.M.1    Goodwin, B.2    Pepsin, P.3
  • 31
    • 15144348812 scopus 로고    scopus 로고
    • Evaluation of general quality of life using the SF-36 in asthmatics receiving inhaled fluticasone propionate 500 μg/day, triamcinolone acetonide 800 μg/day or placebo
    • Cox FM, Goodwin B, Pepsin P et al. Evaluation of general quality of life using the SF-36 in asthmatics receiving inhaled fluticasone propionate 500 μg/day, triamcinolone acetonide 800 μg/day or placebo. Am J Respir Crit Care Med 1996c; 153: A801.
    • (1996) Am J Respir Crit Care Med , vol.153
    • Cox, F.M.1    Goodwin, B.2    Pepsin, P.3
  • 32
    • 0027491554 scopus 로고
    • A dose-ranging study of fluticasone propionate in adult patients with moderate asthma
    • Dahl R, Lundbäck B, Malo J-L et al. A dose-ranging study of fluticasone propionate in adult patients with moderate asthma. Chest 1993; 104: 1352-1358.
    • (1993) Chest , vol.104 , pp. 1352-1358
    • Dahl, R.1    Lundbäck, B.2    Malo, J.-L.3
  • 33
    • 13044306281 scopus 로고
    • The safety and efficacy of fluticasone propionate 200 μg daily given via the Diskhaler inhaler as compared with the pressurised metered dose inhaler in adult asthma
    • Dahl R, on Behalf of an International Group. The safety and efficacy of fluticasone propionate 200 μg daily given via the Diskhaler inhaler as compared with the pressurised metered dose inhaler in adult asthma. Clin Exp Allergy 1993; 23 (Suppl 1): 81.
    • (1993) Clin Exp Allergy , vol.23 , Issue.1 SUPPL. , pp. 81
    • Dahl, R.1
  • 34
    • 0016746139 scopus 로고
    • Pharmacokinetics of inhaled substances
    • Davies DS. Pharmacokinetics of inhaled substances. Postgrad Med J 1975; 51 (Suppl 7): 69-75.
    • (1975) Postgrad Med J , vol.51 , Issue.7 SUPPL. , pp. 69-75
    • Davies, D.S.1
  • 35
    • 0022498062 scopus 로고
    • A double-blind group comparative trial of nedocromil sodium and placebo in the management of bronchial asthma in steroid-dependent patients
    • Dorrow P. A double-blind group comparative trial of nedocromil sodium and placebo in the management of bronchial asthma in steroid-dependent patients. Eur J Respir Dis 1986; 69 (Suppl 147): 317-319.
    • (1986) Eur J Respir Dis , vol.69 , Issue.147 SUPPL. , pp. 317-319
    • Dorrow, P.1
  • 36
    • 0027509447 scopus 로고
    • The clinical efficacy of inhaled nedocromil sodium (Tilade) in the treatment of asthma
    • Edwards AM, Stevens MT. The clinical efficacy of inhaled nedocromil sodium (Tilade) in the treatment of asthma. Eur Respir J 1993; 6: 35-41.
    • (1993) Eur Respir J , vol.6 , pp. 35-41
    • Edwards, A.M.1    Stevens, M.T.2
  • 37
    • 0027162055 scopus 로고
    • Comparison of fluticasone propionate with beclomethasone dipropionate in moderate to severe asthma treated for one year
    • Fabbri L, Burge PS, Croonenborgh L et al. Comparison of fluticasone propionate with beclomethasone dipropionate in moderate to severe asthma treated for one year. Thorax 1993; 48: 817-823.
    • (1993) Thorax , vol.48 , pp. 817-823
    • Fabbri, L.1    Burge, P.S.2    Croonenborgh, L.3
  • 38
    • 0023036808 scopus 로고
    • A trial comparing nedocromil sodium (Tilade) and placebo in the management of bronchial asthma
    • Fyans PFG, Chatterjee PC, Chatterjee SS. A trial comparing nedocromil sodium (Tilade) and placebo in the management of bronchial asthma. Clin Allergy 1986; 16: 505-511.
    • (1986) Clin Allergy , vol.16 , pp. 505-511
    • Fyans, P.F.G.1    Chatterjee, P.C.2    Chatterjee, S.S.3
  • 41
    • 0003736036 scopus 로고
    • NIH Publication No. 95-3659. Bethesda, MD: National Institutes of Health, National Heart, Lung and Blood Institute
    • Global Initiative for Asthma. Global strategy for asthma management and prevention. NIH Publication No. 95-3659. Bethesda, MD: National Institutes of Health, National Heart, Lung and Blood Institute, 1995.
    • (1995) Global Strategy for Asthma Management and Prevention
  • 42
    • 0344569677 scopus 로고    scopus 로고
    • Inhaled fluticasone propionate (FP) 500 μg/day improves asthma-specific quality of life more than triamcinolone acetonide (TAA) 800 μg/day or placebo (PL)
    • Goodwin B, Cox FM, Noonan M, Rogenes P, Wisniewski M. Inhaled fluticasone propionate (FP) 500 μg/day improves asthma-specific quality of life more than triamcinolone acetonide (TAA) 800 μg/day or placebo (PL). Eur Resp J 1996a; 9 (Suppl 23): 80s.
    • (1996) Eur Resp J , vol.9 , Issue.23 SUPPL.
    • Goodwin, B.1    Cox, F.M.2    Noonan, M.3    Rogenes, P.4    Wisniewski, M.5


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.